FDA Approves Sorilux for Adolescent Plaque Psoriasis
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
Rozbeh Torabi, MD, and Radbeh Torabi, MD, discuss the anatomical changes associated with long-term breast augmentation and how they influence explantation planning, reshaping, and outcomes.